| Curt Hammill, DPT | |
|
12 Mt Highway 28, Plains, MT 59859-9601 | |
| (406) 826-4383 | |
| (406) 826-4384 |
| Full Name | Curt Hammill |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 12 Mt Highway 28, Plains, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033664826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PTP-PT-LIC-11121 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Plains Physical Therapy Pc | 8022178292 | 7 |
News Archive
HIV infects certain cells in the brain called microglia, and infected microglia release toxic and inflammatory molecules that can impair or kill surrounding neurons.
Cervical, uterine and ovarian cancers are among the most common cancers affecting women, with a total of 1,087,000 new cases diagnosed worldwide in 2012.
Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
A new test developed at CHU Sainte-Justine in Montreal will enable better management of patients with severe combined immunodeficiency.
› Verified 9 days ago
| Provider Name | Dodge Works Pt, Inc Dba Alpine Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306858642 PECOS PAC ID: 0749285179 Enrollment ID: O20060919000078 |
News Archive
HIV infects certain cells in the brain called microglia, and infected microglia release toxic and inflammatory molecules that can impair or kill surrounding neurons.
Cervical, uterine and ovarian cancers are among the most common cancers affecting women, with a total of 1,087,000 new cases diagnosed worldwide in 2012.
Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
A new test developed at CHU Sainte-Justine in Montreal will enable better management of patients with severe combined immunodeficiency.
› Verified 9 days ago
| Provider Name | Plains Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235389909 PECOS PAC ID: 8022178292 Enrollment ID: O20081118000220 |
News Archive
HIV infects certain cells in the brain called microglia, and infected microglia release toxic and inflammatory molecules that can impair or kill surrounding neurons.
Cervical, uterine and ovarian cancers are among the most common cancers affecting women, with a total of 1,087,000 new cases diagnosed worldwide in 2012.
Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
A new test developed at CHU Sainte-Justine in Montreal will enable better management of patients with severe combined immunodeficiency.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Curt Hammill, DPT Po Box 190, Plains, MT 59859-0190 Ph: (406) 826-4383 | Curt Hammill, DPT 12 Mt Highway 28, Plains, MT 59859-9601 Ph: (406) 826-4383 |
News Archive
HIV infects certain cells in the brain called microglia, and infected microglia release toxic and inflammatory molecules that can impair or kill surrounding neurons.
Cervical, uterine and ovarian cancers are among the most common cancers affecting women, with a total of 1,087,000 new cases diagnosed worldwide in 2012.
Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.
The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.
A new test developed at CHU Sainte-Justine in Montreal will enable better management of patients with severe combined immunodeficiency.
› Verified 9 days ago
Emily Christine Herndon, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 Hubbard St, Plains, MT 59859 Phone: 406-531-5395 | |
Ross Eckstein, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 | |
Stuart Meints, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 | |
Dr. Noah M Bray, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 South Hubbard St, Plains, MT 59859 Phone: 406-826-4384 | |
Mrs. Nicole Lynn Feliksa, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 Fax: 406-826-4394 |